Pharmacokinetics of telithromycin using bronchoscopic microsampling after single and multiple oral doses

Pulmonary Pharmacology and Therapeutics

Volumn 20, Issue 5, 2007, Pages 549-555

  Kikuchi, Junko ^a   Yamazaki, Koichi ^a   Kikuchi, Eiki ^a   Ishizaka, Akitoshi ^b   Nishimura, Masaharu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antimicrobial agent; Bronchoscopic microsampling; Bronchoscopy; Epithelial lining fluid; Pharmacokinetics; Telithromycin

Indexed keywords

TELITHROMYCIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BRONCHOSCOPIC MICROSAMPLING; BRONCHOSCOPY; DRUG BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LUNG LAVAGE; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BRONCHI; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; DRUG ADMINISTRATION SCHEDULE; HUMANS; KETOLIDES; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 34447530155     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2006.05.006     Document Type: Article

References (26)

1. Honeybourne D. Antibiotic penetration in the respiratory tract and implications for the selection of antimicrobial therapy. Curr Opin Pulm Med 3 (1997) 170-174
2. Baldwin D.R., Honeybourne D., and Wise R. Pulmonary disposition of antimicrobial agents: methodological considerations. Antimicrob Agents Chemother 36 (1992) 1171-1175
3. Ishizaka A., Watanabe M., Yamashita T., et al. New bronchoscopic microsample probe to measure the biochemical constituents in epithelial lining fluid of patients with acute respiratory distress syndrome. Crit Care Med 29 (2001) 896-898
4. Ishizaka A., Matsuda T., Albertine K.H., et al. Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 286 (2004) L1088-L1094
5. Watanabe M., Ishizaka A., Ikeda E., et al. Contributions of bronchoscopic microsampling in the supplemental diagnosis of small peripheral lung carcinoma. Ann Thorac Surg 76 (2003) 1668-1673
6. Yamazaki K., Ogura S., Ishizaka A., et al. Bronchoscopic microsampling method for measuring drug concentration in epithelial lining fluid. Am J Respir Crit Care Med 168 (2003) 1304-1307
7. Barry A.L., Fuchs P.C., and Brown S.D. Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (Quinupristin-Dalfopristin), a macrolide (Erythromycin), and a lincosamide (Clindamycin). Antimicrob Agents Chemother 42 (1998) 945-946
8. Pankuch G.A., Visalli M.A., Jacobs M.R., et al. Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents. Antimicrob Agents Chemother 42 (1998) 624-630
9. Reinert R.R., Bryskier A., and Lütticken R. In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany. Antimicrob Agents Chemother 42 (1998) 1509-1511
10. Bebear C.M., Renaudin H., Aydin M.D., et al. In-vitro activity of ketolides against mycoplasmas. J Antimicrob Chemother 39 (1997) 669-670
11. Roblin P.M., and Hammerschlag M.R. In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae. Antimicrob Agents Chemother 42 (1998) 1515-1516
12. Schülin T., Wennersten C.B., Ferraro M.J., et al. Susceptibilities of Legionella spp to newer antimicrobials in vitro. Antimicrob Agents Chemother 42 (1998) 1520-1523
13. Muller-Serieys C., Soler P., Cantalloube C., et al. Bronchopulmobnary disposition of the ketolide telithromycin (HMR3647). Antimicrob Agents Chemother 45 (2001) 3104-3108
14. Crocker C.L. Rapid determination of urea nitrogen in serum or plasma without deproteinization. Am J Med Technol 33 (1967) 361-365
15. Rennard S.I., Basset G., Lecossier D., et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as a marker of dilution. J Appl Physiol 60 (1986) 532-538
16. Nishino T. Kokinryoku. Jpn J Chemother 51 (2003) 511-514 (in Japanese)
17. Heinze A., and Holzgrabe U. Determination of the extent of protein binding of antibiotics by means of an automated continuous ultrafiltration method. Int J Pharm 311 (2006) 108-112
18. Boswell F.J., Andrews J.M., Ashby J.P., et al. The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent. J Antimicrob Chemother 42 (1998) 703-709
19. Schentag J.J. Clinical significance of antibiotic tissue penetration. Clin Pharmacokinet 16 Suppl 1 (1989) 25-31
20. Khair O.A., Andrews J.M., Honeybourne D., et al. Lung concentrations of telithromycin after oral dosing. J Antimicrob Chemother 47 (2001) 837-840
21. Muller-Serieys C., Soler P., Cantalloube C., et al. Bronchopulmonary disposition of the ketolide telithromycin (HMR 3647). Antimicrob Agents Chemother 45 (2001) 3104-3108
22. Kadota J., Ishimatsu Y., Iwashita T., et al. Intrapulmonary pharmacokinetics of telithromycin, a new ketolide, in healthy Japanese volunteers. Antimicrob Agents Chemother 46 (2002) 917-921
23. Zhanel G.G., Walters M., Noreddin A., et al. The ketolides: a critical review. Drugs 62 (2002) 1771-1804
24. Drusano G. Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telithromycin. Clin Microbiol Infect 7 (2001) 24-29
25. Baldwin D.R., Honeybourne D., and Wise R. Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance. Antimicrob Agents Chemother 36 (1992) 1176-1180
26. Vazifeh D., Preira A., Bryskier A., et al. Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophils. Antimicrob Agents Chemother 42 (1998) 1944-1951